Abiopharma

Veillon-Berteloot Chantal 🟡 adjusted position in 36.4K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) at $9.61 Transaction Date: Mar 11, 2026 | Filing ID: 000002

(99% Neutral) STRYKER CORPORATION (SYK) Announces Regulatory Update

Director Poul Mojdeh 🟢 acquired 343.4K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: Mar 11, 2026 | Filing ID: 000003

Hutchinson Michael Damon 🟢 acquired 70.3K shares (1 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Transaction Date: Mar 11, 2026 | Filing ID: 000004

(99% Neutral) CHEMOURS COMPANY (THE) (CC) Files Form 8-K

(99% Neutral) CRYO-CELL INTERNATIONAL, INC. (CCEL) Announces Business Combination

Williams Michelle LeRoux 🟡 adjusted position in 4.6K shares (1 derivative) of ELUTIA INC. (ELUT) at $1.09 Transaction Date: Mar 10, 2026 | Filing ID: 000004

📋 MIKA NISHIMURA (Director) plans to sell 4K shares of SI-BONE, INC. (at $13.83 each, total $57K) Filed: Mar 12, 2026 | ID: 002554

New Form SCHEDULE 13D/A - Pacira BioSciences, Inc. <b>Filed:</b> 2026-03-12 <b>AccNo:</b> 0001011438-26-000180 <b>Size:</b> 58 KB

TZIANABOS ARTHUR 🟡 adjusted position in 4.4K shares (1 derivative) of Stoke Therapeutics, Inc. (STOK) at $40.00 Transaction Date: Mar 10, 2026 | Filing ID: 000002